FIELD: medicine.
SUBSTANCE: blood serum is analysed to determine concentrations of soluble apoptosis markers - sAPO-1 (sAPO-1/Fas), sFas-ligand (sFasL), annexin V (Anx) and anti-phosphatidyl serine (Anti-PS) antibodies by enzyme immunoassay. A formula is used to calculate a prognostic coefficient K. If K is less than 29%, the low risk is stated; the coefficient of 30-50% shows the moderate risk; the coefficient of 51-61% is an indicator of the high risk, whereas the very high risk of unfavourable cardiovascular events is shown by the coefficient of more than 61%.
EFFECT: invention provides the effective assessment of the risk of unfavourable cardiovascular events in the patients with clinical manifestations of atherosclerosis.
1 dwg, 2 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING ADVERSE CARDIOVASCULAR EVENTS FOR A PERIOD OF 12 MONTHS IN PATIENTS WITH CHRONIC HEART FAILURE WITH RECURRENCE OF ANGINA AFTER MYOCARDIAL REVASCULARIZATION | 2018 |
|
RU2677611C1 |
| METHOD FOR PREDICTING COMPLICATIONS IN PATIENTS WITH CHRONIC HEART FAILURE AFTER CARDIAC SURGERIES WITH ARTIFICIAL CIRCULATION | 2017 |
|
RU2680602C1 |
| METHOD FOR LIABILITY TO DEVELOPMENT OF ATHEROSCLEROSIS IN MIDDLE-AGED MEN | 2020 |
|
RU2738975C1 |
| METHOD OF PREDICTING PROBABILITY OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY HEART DISEASE WHO HAVE UNDERGONE PLANNED CORONARY MYOCARDIAL REVASCULARIZATION | 2023 |
|
RU2814112C1 |
| METHOD FOR PREDICTING THE RISK OF THE UNFAVORABLE OUTCOME IN THE PATIENTS SUFFERING ISCHEMIC HEART DISEASE WITHIN THE YEAR FOLLOWING CORONARY ARTERIAL BYPASS | 2019 |
|
RU2704956C1 |
| METHOD FOR ASSESSING THE RISK OF DEVELOPING ATHEROSCLEROSIS BASED ON DETERMINATION OF SERUM LEVEL OF INTERLEUKIN-33 | 2019 |
|
RU2721689C1 |
| METHOD FOR FORECASTING THE ONE-YEAR RISK OF DEVELOPMENT OF ADVERSE CARDIOVASCULAR EVENTS AFTER STENTING OF CORONARY ARTERIES IN PATIENTS WITH CORONARY HEART DISEASE WITH METABOLIC SYNDROME WITHOUT INSULIN RESISTANCE | 2017 |
|
RU2663496C1 |
| METHOD FOR PREDICTING ADVERSE CARDIOVASCULAR EVENTS WITHIN ONE YEAR AFTER A MYOCARDIAL INFARCTION BASED ON MOLECULAR GENETIC ANALYSIS | 2021 |
|
RU2767269C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF CHRONIC CARDIAC INSUFFICIENCY IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2014 |
|
RU2599501C1 |
| METHOD OF PREDICTING RISK OF DEVELOPMENT OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY HEART DISEASE AND TYPE 2 DIABETES WITH PRIOR CORONARY ARTERY STENTING | 2015 |
|
RU2582291C1 |
